SLNO
Soleno Therapeutics Inc Earnings Dividend
$52.9
Earnings Summary
Revenue | $91.73Mn |
Net Profits | $43.36Mn |
Net Profit Margins | 47.27% |
Soleno Therapeutics Inc’s revenue jumped +Inf% since last year same period to $91.73Mn in the Q4 2025. On a quarterly growth basis, Soleno Therapeutics Inc has generated 38.95% jump in its revenue since last 3-months.
Soleno Therapeutics Inc’s net profit jumped 177.45% since last year same period to $43.36Mn in the Q4 2025. On a quarterly growth basis, Soleno Therapeutics Inc has generated 66.68% jump in its net profits since last 3-months.
Soleno Therapeutics Inc’s net profit margin jumped NaN% since last year same period to 47.27% in the Q4 2025. On a quarterly growth basis, Soleno Therapeutics Inc has generated 19.96% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.22 |
EPS Estimate Current Year | 0.22 |
Soleno Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.22 - a 330% jump from last quarter’s estimates.
Soleno Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.22.
Key Ratios
Earning Per Share (EPS) | 0.8 |
Soleno Therapeutics Inc’s earning per share (EPS) jumped 162.99% since last year same period to 0.8 in the Q4 2025. This indicates that the Soleno Therapeutics Inc has generated 162.99% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-02-25 | 0.22 | 0.8 | 272.09% |
2025-05-07 | -0.93 | -0.95 | -2.43% |
2025-08-06 | -0.64 | -0.09 | 85.94% |
2025-11-04 | 0.05 | 0.47 | 840% |
